GPA

Clinical trials for GPA explained in plain language.

Never miss a new study

Get alerted when new GPA trials appear

Sign up with your email to follow new studies for GPA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug may ease ENT symptoms in rare autoimmune disease

Disease control Not yet recruiting

This study tests whether adding TAVNEOS to standard treatment helps control ear, nose, and throat symptoms in people with granulomatosis with polyangiitis (GPA), a rare autoimmune disease. About 30 adults with active ENT disease will receive either TAVNEOS or a placebo for 52 wee…

Matched conditions: GPA

Phase: PHASE2, PHASE3 • Sponsor: Robert Spiera, MD • Aim: Disease control

Last updated May 12, 2026 13:42 UTC

GPA

Get alerted when new GPA trials appear

New drug may ease ENT symptoms in rare autoimmune disease